Here are five key takeaways:
1. The LigaPASS 2.0 generation technology features number of improvements from the initial technology.
2. The technology is now cleared for use in adolescent idiopathic and neuromuscular scoliosis patients 10 years of age and older.
3. The technology includes two new connectors — the LigaPASS LP and the LigaPASS Open.
4. The first iteration of LigaPASS has been used in more than 5,000 surgeries worldwide in the past two years.
5. Medicrea focuses on the design, manufacture and distribution of innovative technologies for patient-specific spinal surgery. The company received FDA clearance for the UNiD late last year.
More articles on devices:
European orthopedic trauma market — 8 key trends
Alphatec Spine appoints Donald A. Williams to board of directors — 5 key notes
Alphtec Spine net revenue up 5% in Ql: 10 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
